BiotechTube
Home/Poseida Therapeutics/Kristin Yarema
KY

Kristin Yarema

President and Chief Operating Officer

Poseida Therapeutics

Therapeutic Areas

OncologyRare Diseases

Poseida Therapeutics Pipeline

DrugIndicationPhase
P-BCMA-ALLO1Relapsed/Refractory Multiple MyelomaPhase 1
P-MUC1C-ALLO1Solid Tumors (Breast, Ovarian, Pancreatic, etc.)Phase 1
P-PSMA-ALLO1Metastatic Castration-Resistant Prostate CancerPhase 1
P-BCMA-101Relapsed/Refractory Multiple MyelomaPhase 1/2
P-MOD-501Ornithine Transcarbamylase (OTC) DeficiencyPreclinical

Leadership Team at Poseida Therapeutics

EO
Eric Ostertag
Chief Executive Officer
SR
Syed Rizvi
Chief Medical Officer
BA
Bryan A. Kobel
Chief Financial Officer
BW
Brent Warner
President, Gene Therapy
MT
Matthew T. Spear
Chief Development Officer (former)
View full Poseida Therapeutics profile